Literature DB >> 18181723

Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs.

Freddie Ann Hoffman1, James T Heimbach, Mary Ellen Sanders, Patricia L Hibberd.   

Abstract

Mesh：

Year:  2008        PMID： 18181723     DOI： 10.1086/523342

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  17 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 2.  Future novel therapeutic agents for Clostridium difficile infection.

Authors:  Hoonmo L Koo; Kevin W Garey; Herbert L Dupont
Journal:  Expert Opin Investig Drugs       Date:  2010-07       Impact factor: 6.206

3.  Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.

Authors:  Elaine O Petrof
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-09-01

4.  'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics.

Authors:  Krista L Harrison; Ruth M Farrell; Margaret A Brinich; Janelle Highland; MaryBeth Mercer; Jennifer B McCormick; Jon Tilburt; Gail Geller; Patricia Marshall; Richard R Sharp
Journal:  Health Expect       Date:  2012-12-28       Impact factor: 3.377

Review 5.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

6.  Probiotics and necrotizing enterocolitis: finding the missing pieces of the probiotic puzzle.

Authors:  Sherry A Luedtke; Jacob T Yang; Heather E Wild
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

Review 7.  Probiotics During the Therapeutic Management of Periodontitis.

Authors:  Flávia Furlaneto; Karin Hitomi Ishikawa; Michel Reis Messora; Marcia P A Mayer
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

8.  Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.

Authors:  J S Bajaj; D M Heuman; P B Hylemon; A J Sanyal; P Puri; R K Sterling; V Luketic; R T Stravitz; M S Siddiqui; M Fuchs; L R Thacker; J B Wade; K Daita; S Sistrun; M B White; N A Noble; C Thorpe; G Kakiyama; W M Pandak; M Sikaroodi; P M Gillevet
Journal:  Aliment Pharmacol Ther       Date:  2014-03-16       Impact factor: 8.171

9.  Strain-specific genotyping of Bifidobacterium animalis subsp. lactis by using single-nucleotide polymorphisms, insertions, and deletions.

Authors:  Elizabeth P Briczinski; Joseph R Loquasto; Rodolphe Barrangou; Edward G Dudley; Anastasia M Roberts; Robert F Roberts
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

10.  Cell-bound Exopolysaccharide Extract from Indigenous Probiotic Bacteria Induce Apoptosis in HT-29 cell-line.

Authors:  Parisa Mojibi; Farzaneh Tafvizi; Maryam Bikhof Torbati
Journal:  Iran J Pathol       Date:  2018-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.